galactose has been researched along with Glomerulonephritis, IGA in 124 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.61) | 18.7374 |
1990's | 6 (4.84) | 18.2507 |
2000's | 15 (12.10) | 29.6817 |
2010's | 54 (43.55) | 24.3611 |
2020's | 47 (37.90) | 2.80 |
Authors | Studies |
---|---|
Artan, AS; Caliskan, Y; Demir, E; Dirim, AB; Karatay, E; Lentine, KL; Mirioglu, S; Oto, OA; Ozluk, Y; Savran Oguz, F; Turkmen, A; Usta Akgul, S; Yazici, H | 1 |
Harada, S; Kawai, S; Nakamura, T; Nobori, S; Shirouzu, T; Sugimoto, R; Ushigome, H; Yoshikawa, M | 1 |
Benhamou, M; Bhukhai, K; Casadevall, N; Cohen, C; Coulon, S; Dussiot, M; El Karoui, K; Favale, F; Flamant, M; Fouquet, G; Hermine, O; Hummel, A; Knebelmann, B; Legendre, C; Maciel, TT; Mesnard, L; Monteiro, RC; Moura, IC; Moutereau, S; Neuraz, A; Nguyen-Khoa, T; Rondeau, E; Stang, ML; Vrtovsnik, F | 1 |
Baudouin, V; Cambier, A; Couderc, A; Dossier, C; Gleeson, PJ; Hogan, J; Kwon, T; Maisin, A; Monteiro, RC | 1 |
Jia, J; Li, H; Liu, Y; Wang, F; Yan, T; Yu, H | 1 |
Barratt, J; Cheung, CK | 2 |
Groza, Y; Jemelkova, J; Kafkova, LR; Maly, P; Raska, M | 1 |
Kano, T; Makita, Y; Nakano, D; Nishiyama, A; Novak, J; Suzuki, H; Suzuki, Y; Yanagawa, H | 1 |
Abe, K; Akiyama, M; Gunji, M; Honda, K; Iyoda, M; Kang, D; Kodama, M; Sako, M; Shimomura, K; Takaki, T; Wada, Y; Yoshimoto, H | 1 |
Crossman, DK; Reily, C; Rice, T; Rizk, DV | 1 |
Bai, JY; Huang, D; Liang, TY; Meng, W; Shen, JJ; Shen, PC; Wang, LB; Wu, Q | 1 |
Bin, S; Cravedi, P; Faith, J; Rajasekaran, A; Sanchez-Russo, L | 1 |
Ang, MD; Chen, YS; Chiang, WC; Chiu, YL; Chou, SF; Tsai, CC; Yang, CW | 1 |
Fang, M; Li, L; Nie, L; Si, M; Yang, W; Ye, Z; Yu, X; Zhang, XC | 1 |
Chang, WC; Chen, GY; Chen, HF; Chen, HH; Chen, MX; Ka, SM; Kao, CC; Lai, RY; Lin, YC; Tsai, IL; Wang, SY; Weng, TI; Wu, MS; Yeh, SC | 1 |
Cheng, H; Cheng, W; Dong, H; Geng, Y; Guo, W; Sun, L; Wang, G; Xu, X; Ye, S | 1 |
Liang, Y; Wang, XH; Yan, L; Yu, RH; Zeng, Q | 1 |
Futamura, K; Kano, T; Nishihira, M; Oguchi, H; Sofue, T; Suzuki, H; Toyoda, M; Tsujita, M; Yazawa, M | 1 |
Hou, X; Jiang, X; Liu, S; Song, Y; Tang, X; Wan, F; Ye, T; Yu, J; Zhang, M; Zheng, J | 1 |
Aoki, R; Ito, S; Lee, M; Matsumoto-Nakano, M; Matsuoka, D; Misaki, T; Nagasawa, Y; Naka, S; Nakano, K; Nomura, R; Suzuki, H; Suzuki, Y | 1 |
Gong, Z; Hu, W; Liu, X; Mu, J; Song, X; Su, Y; Tang, J | 1 |
Maixnerova, D; Tesar, V | 1 |
Barneoud-Rousset, O; Bechtler, C; Hänggi, P; König, KF; Martin, K; Pang, L; Pearson, N; Ricklin, D | 1 |
Boi, R; Ebefors, K; Elíasdóttir, S; Guron, G; Khramova, A; Mölne, J; Nyström, J; Saeed, A | 1 |
Li, S; Lin, L; Shen, J; Wu, X; You, Y | 1 |
Barratt, J; Boor, P; Floege, J; Kramann, R; Seikrit, C; Stamellou, E; Tang, SCW; Tesař, V | 1 |
Barratt, J; Didangelos, A; Nanni, P; Pieri, K; Taylor, S; Tica, J | 1 |
Brown, R; Fatima, H; Hall, S; Huang, ZQ; Julian, BA; Novak, J; Novak, L; Rizk, DV; Saha, MK | 1 |
Hao, C; Lai, L; Liu, T; Qian, J; Shang, D; Xue, J; Yan, M | 1 |
Jia, J; Liu, X; Liu, Y; Yan, T; Zheng, J | 1 |
Gao, S; Jia, J; Li, H; Li, Q; Lin, S; Liu, Y; Shang, W; Wei, L; Yan, T; Zhang, K; Zhang, Y | 1 |
Chen, P; Liu, L; Lv, J; Shi, S; Wang, M; Xu, D; Yu, G; Zhang, H; Zhao, M; Zhou, X | 1 |
Julian, BA; Kano, T; Makita, Y; Novak, J; Suzuki, H; Suzuki, Y; Takahata, A | 1 |
Ara Del Rey, J; Esteve Cols, C; Graterol Torres, FA; Marco Rusiñol, H; Martínez Cáceres, EM; Navarro Díaz, MI; Quirant Sánchez, B | 1 |
Abe, M; Akiyama, M; Honda, K; Iyoda, M; Kanazawa, N; Shibata, T; Shikida, Y; Sugiyama, M; Wada, Y | 1 |
Honda, H; Iyoda, M; Kanazawa, N; Matsumoto, K; Shibata, T; Sugiyama, M; Suzuki, T; Tachibana, S; Wada, Y | 1 |
Chen, G; Chen, S; Lan, Z; Liu, H; Liu, Y; Peng, L; Yang, D; Yuan, S; Zhao, L; Zhu, X | 1 |
Inoue, N; Irabu, H; Kaneko, S; Mizuta, M; Ohta, K; Shimizu, M; Yachie, A | 1 |
Hattori, M; Honda, K; Ishizuka, K; Miura, K; Nagasawa, T; Shirai, Y; Suzuki, H; Suzuki, Y; Takahashi, K; Taneda, S; Yabuuchi, T; Yamaguchi, Y | 1 |
Fukao, Y; Kano, T; Kato, R; Lee, M; Makita, Y; Nakayama, M; Suzuki, H; Suzuki, Y | 1 |
Jia, J; Liu, Y; Wang, F; Yan, T; Zhang, Y | 1 |
Chen, W; Dong, Y; Fan, J; Luo, N; Tan, J; Wang, B; Xie, K; Ye, H; Yu, X; Zheng, N | 1 |
Aoto, Y; Fujimaru, R; Fujimura, J; Horinouchi, T; Iijima, K; Ishiko, S; Ishimori, S; Kaito, H; Kamiyoshi, N; Kondo, A; Nagai, S; Nagano, C; Nagase, H; Nakanishi, K; Nozu, K; Sakakibara, N; Shima, Y; Tanaka, R; Yamamura, T; Yoshikawa, N; Yoshimura, M | 1 |
Isaka, N; Katsuma, A; Katsumata, H; Kawabe, M; Kimura, T; Kobayashi, A; Koike, K; Koike, Y; Kojima, H; Miki, J; Nakada, Y; Ohkido, I; Tanno, Y; Tsuboi, N; Ueda, H; Yamada, H; Yamakawa, T; Yamamoto, H; Yamamoto, I; Yokoo, T | 1 |
Han, W; Ichikawa, D; Koike, J; Nakata, M; Oda, T; Shibagaki, Y; Suzuki, H; Suzuki, T; Suzuki, Y; Watanabe, S | 1 |
Chen, P; Hou, P; Liu, LJ; Lv, JC; Shi, SF; Wang, YN; Yu, GZ; Zhang, H; Zhang, X; Zhou, XJ | 1 |
Hastings, MC; Kiryluk, K; Nelson, R; Novak, J; Rizk, DV; Wyatt, RJ; Zahr, RS | 1 |
Clerc, F; Cook, HT; Dotz, V; Falchi, M; Hipgrave Ederveen, AL; Lomax-Browne, HJ; Medjeral-Thomas, NR; Pickering, MC; Visconti, A; Wuhrer, M | 1 |
Chang, FC; Chen, YM; Chiang, WC; Chiu, YL; Chou, YH; Fang, YW; Lin, SL; Lin, WC; Shu, KH; Wu, CF; Wu, MS | 1 |
Bu, L; Kim, Y; Riad, S; Spong, R; Su, X | 1 |
Akgul, SU; Artan, AS; Caliskan, B; Caliskan, Y; Demir, E; Kekik, C; Oguz, FS; Sever, MS; Temurhan, S; Turkmen, A; Yazici, H | 1 |
Kano, T; Makita, Y; Sofue, T; Suzuki, H; Suzuki, Y; Tanbo, Y; Yamasaki, K; Yasutake, J | 1 |
Floege, J | 1 |
Julian, BA; Novak, J; Reily, C; Rizk, DV | 1 |
Kiryluk, K; Neugut, YD | 1 |
Suzuki, H; Suzuki, Y | 1 |
Iseri, K; Iyoda, M; Kanazawa, N; Matsumoto, K; Saito, T; Shibata, T; Sugiyama, M; Suzuki, T; Tachibana, S; Wada, Y | 1 |
Suzuki, H; Suzuki, Y; Yamasaki, K; Yamazaki, Y; Yasutake, J | 1 |
Ding, YF; Duan, CR; Fu, RQ; Kang, ZJ; Li, ZH; Liu, B; Wu, TH; Xun, M; Zhang, Y | 1 |
Brown, R; Hall, S; Honsova, E; Ling, C; Maixnerova, D; Neprasova, M; Novak, J; Reily, C; Suchanek, M; Tesar, V; Zima, T | 1 |
Agarwal, SK; Bagchi, S; Balooni, V; Barwad, A; Bhowmik, D; Lingaiah, R; Mani, K; Singh, G | 1 |
Akihisa, T; Akiyama, K; Iwabuchi, Y; Kamiyama, M; Kamiyama, T; Karasawa, K; Kyoda, M; Manabe, S; Miyabe, Y; Moriyama, T; Nakano, M; Nitta, K; Ogura, S; Sato, M; Suzuki, S; Takabe, T; Uchida, K; Yamaguchi, E | 1 |
Jia, J; Liu, Y; Yan, T; Zhao, N; Zheng, J | 1 |
Alberton, V; Bott, C; Cassol, CA; Malvar, A; Nadasdy, GM; Nadasdy, T; Nagaraja, HN; Rovin, BH; Satoskar, AA | 1 |
Liu, L; Lv, J; Shi, S; Xie, X; Zhang, H; Zhang, X | 1 |
Berthoux, F; Hastings, MC; Julian, BA; Moldoveanu, Z; Novak, J; Renfrow, MB; Sanders, JT; Suzuki, H; Wyatt, RJ | 1 |
Jiang, YF; Li, C; Ma, L; Wang, YY; Zhang, L; Zhao, PW; Zou, HB | 1 |
Gharavi, AG; Julian, BA; Moldoveanu, Z; Novak, J; Raska, M; Suzuki, H; Tomino, Y; Wyatt, RJ; Yamada, K | 1 |
Horikoshi, S; Hotta, O; Ieiri, N; Matsuoka, J; Matsuzaki, K; Novak, J; Okazaki, K; Sato, M; Sato, T; Suzuki, H; Suzuki, Y; Taguma, Y; Tomino, Y; Yanagawa, H | 1 |
Horikoshi, S; Kano, T; Matsuzaki, K; Nakata, J; Novak, J; Sato, D; Suzuki, H; Suzuki, Y; Tomino, Y; Yanagawa, H | 1 |
Albera, R; Amore, A; Beltrame, G; Benozzi, L; Bergia, R; Boido, A; Camilla, R; Cancarini, G; Chiale, F; Coppo, R; Cravero, R; Cusinato, S; Donadio, ME; Licata, C; Loiacono, E; Magistroni, R; Mariano, F; Mazzucco, G; Peruzzi, L; Quaglia, M; Ravera, S; Rollino, C; Savoldi, S; Stratta, P; Vergano, L | 1 |
Gharavi, AG; Julian, BA; Kiryluk, K; Makita, Y; Matsuoka, K; Novak, J; Suzuki, H; Suzuki, Y; Tomino, Y; Yanagawa, H | 1 |
Aryal, RP; Chapman, AB; Clausen, H; Cummings, RD; Han, Y; Ju, T; Lehoux, S; Mi, R; Schjoldager, KT; van Die, I; Wang, Y | 1 |
Huang, ZQ; Julian, BA; Mestecky, J; Novak, J; Reily, C; Ueda, H; Willey, CD | 1 |
Czernekova, L; Julian, BA; Novak, J; Raska, M; Renfrow, MB; Stewart, TJ; Stuchlova Horynova, M; Suzuki, H; Takahashi, K; Vrablikova, A; Yamada, K | 1 |
Suzuki, H; Suzuki, Y; Tomino, Y; Yasutake, J | 1 |
Coppo, R | 2 |
Hiura, N; Kaneko, E; Makita, Y; Suzuki, H; Suzuki, Y; Tomino, Y; Yanagawa, H; Yasutake, J | 1 |
Candemark, E; Ebefors, K; Elvin, J; Haraldsson, B; Lassén, E; Levan, K; Liu, P; Nyström, J | 1 |
Dicker, M; Maresch, D; Strasser, R | 1 |
Allegri, L; Hall, S; Julian, BA; Moldoveanu, Z; Novak, J; Suzuki, H; Suzuki, Y; Wyatt, RJ | 1 |
Liu, X; Sun, Q; Zhang, H; Zhang, Z | 1 |
Barratt, J; Kim, MJ; Koller, MT; Molyneux, K; Schaub, S; Stampf, S | 1 |
Berthoux, F; Bradbury, D; Chen, N; Eitner, F; Fischman, C; Floege, J; Gharavi, AG; Hou, P; Ionita-Laza, I; Julian, BA; Kiryluk, K; LeDesma, RA; Li, Y; Maillard, N; Mladkova, N; Moldoveanu, Z; Novak, J; Prakash, S; Rauen, T; Reily, C; Scolari, F; Shapiro, S; Suzuki, H; Wyatt, RJ; Xie, J; Zhang, H | 1 |
Barratt, J; Caplin, B; Ferlin, A; Gale, DP; Higgins, P; Kleta, R; Levine, AP; Molyneux, K; Nelson, CP; Samani, NJ; Stanescu, H; Wimbury, D; Yin, P; Yu, X | 1 |
Ara, J | 1 |
Brown, R; Chatham, WW; Fan, R; Hall, S; Julian, BA; Lee, JY; Mestecky, J; Moldoveanu, Z; Novak, J; Robinson, J; Suzuki, H; Suzuki, Y; Tomana, M; Tomino, Y; Wyatt, RJ; Zhang, Z | 1 |
Lau, KK; Novak, J; Suzuki, H; Wyatt, RJ | 1 |
Ding, J; Jiang, L; Lin, X; Shi, S; Zhang, H; Zhao, M; Zhu, L | 1 |
Colvin, GA; Esparza, A; Farooqi, S; Hu, SL; Julian, BA; Novak, J; Rifai, A; Suzuki, H | 1 |
Brooks, MT; Gomes, MM; Herr, AB; Julian, BA; Mestecky, J; Moldoveanu, Z; Novak, J; Suzuki, H; Tomana, M | 1 |
Gharavi, AG; Hastings, MC; Julian, BA; McGlothan, KR; Moldoveanu, Z; Novak, J; Sanders, JT; Wyatt, RJ | 1 |
Segarra, A | 1 |
Amore, A; Appel, GB; Camilla, R; Coppo, R; Daprà, V; Gharavi, AG; Ghiggeri, GM; Julian, BA; Loiacono, E; Mazzucco, G; Novak, J; Peruzzi, L; Scolari, F; Suzuki, H; Troyanov, S | 1 |
Brown, R; Eison, TM; Hall, S; Julian, BA; Matousovic, K; Mayne, R; Mestecky, J; Moldoveanu, Z; Novak, J; Novak, L; Novak, Z; Raskova Kafkova, L; Sanders, JT; Suzuki, H; Tomana, M; Wyatt, RJ | 1 |
Barratt, J; Feehally, J | 1 |
Berthelot, L; Daugas, E; Durand, F; Francoz, C; Lebrec, D; Monteiro, RC; Moreau, R; Morelle, W; Moura, IC; Paradis, V; Tissandié, E; Trawalé, JM; Vrtovsnik, F; Walker, F | 1 |
Gharavi, AG; Herr, AB; Julian, BA; Kiryluk, K; Mestecky, J; Moldoveanu, Z; Novak, J; Renfrow, MB; Scolari, F; Suzuki, H; Wyatt, RJ | 1 |
Julian, BA; Mestecky, J; Novak, J; Renfrow, MB | 1 |
Gharavi, AG; Hou, P; Kiryluk, K; Li, Y; Lv, J; Moldoveanu, Z; Novak, J; Zhang, H; Zhao, N | 1 |
Berthoux, F; Julian, BA; Maillard, N; Mariat, C; Novak, J; Suzuki, H; Thibaudin, L; Tomino, Y; Yanagawa, H | 1 |
Eison, TM; Gaber, L; Hastings, MC; Julian, BA; Lau, KK; Moldoveanu, Z; Novak, J; Sanders, JT; Walker, PD; Wyatt, RJ | 1 |
Xu, LX; Zhao, MH | 1 |
Xu, LX; Yan, Y; Zhang, JJ; Zhang, Y; Zhao, MH | 1 |
Barratt, J; de Wolff, JF; Feehally, J; Molyneux, K; Smith, AC | 1 |
Anreddy, SR; Cook, WJ; Hall, S; Hastings, MC; Huang, WQ; Julian, BA; Lau, KK; Lee, JY; Mestecky, J; Moldoveanu, Z; Novak, J; Tomana, M; Wyatt, RJ | 1 |
Brown, R; Hall, S; Julian, BA; Mestecky, J; Moldoveanu, Z; Novak, J; Suzuki, H; Tomana, M; Tomino, Y; Wyatt, RJ | 1 |
Hogg, RJ; Huang, WQ; Julian, BA; Lau, KK; Lee, JY; Mestecky, J; Moldoveanu, Z; Novak, J; Tomana, M; Wyatt, RJ | 1 |
Chan, LY; Fenn, J; Lai, KN; Leung, JC; Tam, PC; Tang, SC | 1 |
Crowley-Nowick, PA; Jackson, S; Julian, BA; Mestecky, J; Moldoveanu, Z; Tomana, M | 1 |
Julian, BA; Kulhavy, R; Mestecky, J; Tomana, M; Waldo, FB | 1 |
Baharaki, D; Basset, C; Clèdes, J; Dueymes, M; Le Corre, R; Perrichot, R; Youinou, P | 1 |
Julian, BA; Konecny, K; Matousovic, K; Mestecky, J; Radl, J; Tomana, M | 1 |
D'Amico, G | 1 |
Julian, BA; Konecny, K; Matousovic, K; Mestecky, J; Novak, J; Tomana, M | 1 |
Hiki, Y; Iwase, H; Maeda, K; Nishimoto, A; Odani, H; Shinzato, T; Takahashi, M; Yasuda, Y | 1 |
Amore, A; Basso, G; Cirina, P; Coppo, R; Emancipator, SN; Marchisio, PC; Peruzzi, L; Ricotti, E; Trusolino, L | 1 |
Chua, CT; Hashim, OH; Shuib, AS | 1 |
Amore, A; Brusa, P; Cirina, P; Conti, G; Coppo, R; Peruzzi, L | 1 |
Julian, BA; Mesteck, J; Novak, J; Tomana, M | 1 |
Czerkinsky, C; Galla, JH; Julian, BA; Matsuda, S; Mestecky, J; Moldoveanu, Z; Russell, MW; Tarkowski, A; Tomana, M; Waldo, FB | 1 |
Davin, JC; Foidart, J; Mahieu, P; Malaise, M | 1 |
21 review(s) available for galactose and Glomerulonephritis, IGA
Article | Year |
---|---|
IL-6 and its role in IgA nephropathy development.
Topics: Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Interleukin-6 | 2022 |
The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy.
Topics: Antigen-Antibody Complex; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Inflammation; Kidney | 2022 |
Serum galactose-deficient immunoglobulin A1 in recurrent immunoglobulin a nephropathy after kidney transplantation: A meta-analysis.
Topics: Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Failure, Chronic; Kidney Transplantation | 2023 |
Emerging role of monoclonal antibodies in the treatment of IgA nephropathy.
Topics: Antibodies, Monoclonal; Antigen-Antibody Complex; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A | 2023 |
IgA nephropathy.
Topics: Antigen-Antibody Complex; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A | 2023 |
IgA vasculitis with nephritis: update of pathogenesis with clinical implications.
Topics: Child; Galactose; Glomerulonephritis, IGA; Humans; IgA Vasculitis; Immunoglobulin A; Kidney Glomerulus; Nephritis | 2022 |
Genetic Determinants of IgA Nephropathy: Western Perspective.
Topics: Antigen-Antibody Complex; Autoantibodies; Biomarkers; Black or African American; Chromosome Mapping; Galactose; Genetic Predisposition to Disease; Genome-Wide Association Study; Glomerulonephritis, IGA; High-Throughput Nucleotide Sequencing; Humans; Immunoglobulin A; Phenotype; Polysaccharides; White People | 2018 |
Murine Models of Human IgA Nephropathy.
Topics: Animals; Antigens, CD; B-Cell Activating Factor; Disease Models, Animal; Galactose; Gene Knock-In Techniques; Glomerulonephritis, IGA; Glycosylation; Hematuria; Humans; Immunoglobulin A; Lactalbumin; Mice; Mice, Inbred Strains; Mice, Knockout; Mice, Transgenic; Myeloid Differentiation Factor 88; Nephritis; Proteinuria; Receptors, Fc; Sendai virus; Toll-Like Receptor 9; Trichothecenes; Uteroglobin | 2018 |
Biomarkers in IgA nephropathy: relationship to pathogenetic hits.
Topics: Autoantibodies; Biomarkers; Complement Activation; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Lectins; Mass Spectrometry; Peptides | 2013 |
Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
Topics: Animals; Autoimmune Diseases; Galactose; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Glomerulonephritis, IGA; Glycosylation; Glycosyltransferases; Humans; Immunoglobulin A; Signal Transduction | 2014 |
Paradigm shift in activity assessment of IgA nephropathy - optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting.
Topics: Animals; Drug Delivery Systems; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Immunologic Factors; Polysaccharides | 2015 |
Biomarkers and targeted new therapies for IgA nephropathy.
Topics: Biomarkers; Child; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A | 2017 |
Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.
Topics: Biomarkers; Early Diagnosis; Female; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Male; Randomized Controlled Trials as Topic | 2016 |
Pathogenesis of Henoch-Schönlein purpura nephritis.
Topics: Antigen-Antibody Complex; Child; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; IgA Vasculitis; Immune Complex Diseases; Immunoglobulin A | 2010 |
[Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].
Topics: Antigens, CD; Complement Activation; Disease Progression; Forecasting; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Immunoglobulin A, Secretory; Kidney Failure, Chronic; Models, Immunological; Plasma Cells; Protein Processing, Post-Translational; Receptors, Fc; Receptors, Transferrin | 2010 |
Primary IgA nephropathy: new insights into pathogenesis.
Topics: Animals; Antigen-Antibody Complex; Antigens, CD; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Kidney Tubules; Mesangial Cells; Podocytes; Receptors, Fc; Toll-Like Receptors | 2011 |
The pathophysiology of IgA nephropathy.
Topics: Biomarkers; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Mesangial Cells | 2011 |
Glycosylation of IgA1 and pathogenesis of IgA nephropathy.
Topics: Animals; Antigen-Antibody Complex; Autoantibodies; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Kidney; Polysaccharides | 2012 |
IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
Topics: Antibody Specificity; Cell Line, Transformed; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G | 2007 |
Pathogenesis of immunoglobulin A nephropathy.
Topics: Animals; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Glomerulus; Molecular Structure; Polysaccharides | 1998 |
Progress in molecular and genetic studies of IgA nephropathy.
Topics: Animals; Chloride Channels; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Polysaccharides | 2001 |
2 trial(s) available for galactose and Glomerulonephritis, IGA
Article | Year |
---|---|
Abnormal glucose metabolism and galactose-deficient immunoglobulin A1 (IgA1) synthesis: a possible mechanism of IgA nephropathy.
Topics: Adult; Blood Glucose; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Lactase; Male; Middle Aged; Proteinuria | 2019 |
Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
Topics: Adult; Autoantibodies; Biomarkers; Disease Progression; Female; Follow-Up Studies; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Male; Prospective Studies | 2019 |
101 other study(ies) available for galactose and Glomerulonephritis, IGA
Article | Year |
---|---|
Oxidative stress and macrophage infiltration in IgA nephropathy.
Topics: Adolescent; Adult; Advanced Oxidation Protein Products; Aged; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Macrophages; Male; Middle Aged; Oxidative Stress; Young Adult | 2022 |
The Abundance of Antigalactose-deficient IgA1 Autoantibodies Results in Glomerular Deposition and IgA Nephropathy Recurrence After Renal Transplantation.
Topics: Autoantibodies; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Glomerulus; Kidney Transplantation | 2021 |
Erythrocytosis associated with IgA nephropathy.
Topics: Animals; Biomarkers; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Mice; Polycythemia; Retrospective Studies | 2022 |
Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case.
Topics: Antigen-Antibody Complex; Biomarkers; Child; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Prospective Studies; Proteinuria | 2022 |
Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
Topics: Antigen-Antibody Complex; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Mesangial Cells; N-Acetylneuraminic Acid; Young Adult | 2022 |
Further Evidence for the Mucosal Origin of Pathogenic IgA in IgA Nephropathy.
Topics: Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Male | 2022 |
Glomerular deposition of galactose-deficient IgA1-containing immune complexes via glomerular endothelial cell injuries.
Topics: Animals; Antigen-Antibody Complex; Endothelial Cells; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Mice; Mice, Nude | 2022 |
Crohn's disease may promote inflammation in IgA nephropathy: a case-control study of patients undergoing kidney biopsy.
Topics: Biopsy; Case-Control Studies; Crohn Disease; Formaldehyde; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Inflammation; Kidney; Steroids | 2022 |
Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
Topics: Autoantigens; Cytokines; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Leukocytes, Mononuclear; Phosphoric Monoester Hydrolases | 2022 |
Guben Tongluo Formula Protects LPS-induced Damage in Lamina Propria B Lymphocytes Through TLR4/MyD88/NF-κB Pathway.
Topics: Antigen-Antibody Complex; B-Lymphocytes; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Lipopolysaccharides; Mucous Membrane; Myeloid Differentiation Factor 88; NF-kappa B; Signal Transduction; Toll-Like Receptor 4 | 2022 |
Newly-diagnosed immunoglobulin A nephropathy with increased plasma galactose-deficient-IgA
Topics: 2019-nCoV Vaccine mRNA-1273; COVID-19; COVID-19 Vaccines; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Male; Middle Aged; RNA, Messenger; Vaccination | 2022 |
Anomalous kinetics of galactose-deficient IgA incurring nephropathy revealed by cross-scale optical imaging.
Topics: Animals; Galactose; Glomerulonephritis, IGA; Immunoglobulin A; Mice; Mice, Nude; Optical Imaging | 2023 |
Development of an enrichment-free one-pot sample preparation and ultra-high performance liquid chromatography-tandem mass spectrometry method to identify Immunoglobulin A1 hinge region O-glycoforms for Immunoglobulin A nephropathy.
Topics: Chromatography, High Pressure Liquid; Galactose; Glomerulonephritis, IGA; Glycopeptides; Humans; Immunoglobulin A; Tandem Mass Spectrometry | 2022 |
Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients.
Topics: Galactose; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Humans; Immunoglobulin A | 2022 |
Mechanism of Yiqi Yangying Heluo Formula in the Treatment of IgA Nephropathy by Affecting Gd-IgA1 Based on BAFF Molecular Level and T Lymphocyte Immunity.
Topics: Cytokines; Drugs, Chinese Herbal; Galactose; Glomerulonephritis, IGA; Hematuria; Humans; Immunoglobulin A; Interleukin-17; Interleukin-4; Interleukin-6 | 2023 |
Serological and histopathological assessment of galactose-deficient immunoglobulin A1 deposition in kidney allografts: A multicenter prospective observational study.
Topics: Adult; Allografts; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney; Prospective Studies | 2023 |
The significance of galactose-deficient immunoglobulin A1 staining in kidney diseases with IgA deposition.
Topics: Fluorescent Antibody Technique; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Glomerulus | 2023 |
cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy.
Topics: Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Streptococcus mutans | 2023 |
Optimized synthesis, polymer conjugation, and proof-of-concept studies of the gd-IgA1 epitope for antibody-scavenging therapies in IgA nephropathy.
Topics: Antigen-Antibody Complex; Autoantibodies; Epitopes; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A | 2023 |
Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
Topics: Biomarkers; Creatinine; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Renal Insufficiency, Chronic | 2023 |
Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro.
Topics: Animals; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Lipopolysaccharides; Mice; Molecular Chaperones | 2023 |
Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys.
Topics: Adult; Antigen-Antibody Complex; Autoantibodies; B-Lymphocytes; Biomarkers; Biopsy; Case-Control Studies; Female; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney; Kidney Failure, Chronic; Male; Phosphatidylethanolamine Binding Protein | 2019 |
Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
Topics: Adult; Aged; Antibody Specificity; Autoantibodies; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Glomerulus; Male; Middle Aged; Young Adult | 2019 |
Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.
Topics: Adult; Case-Control Studies; Female; Galactose; Gene Expression Profiling; Gene Expression Regulation; Gene Ontology; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Male; PTEN Phosphohydrolase; Reproducibility of Results; RNA, Messenger | 2019 |
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
Topics: Adult; Female; Galactose; Glomerulonephritis, IGA; Humans; Hydrocarbons, Fluorinated; Immunoglobulin A; Male; Urea | 2019 |
Biomarkers to Predict Progression in IgA Nephropathy.
Topics: Biomarkers; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Renal Insufficiency, Chronic | 2019 |
Associations of ABO blood type and galactose-deficient immunoglobulin A1 with adverse outcomes in patients with IgA nephropathy.
Topics: ABO Blood-Group System; Adult; Female; Galactose; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Male; Prognosis; Proteinuria; Retrospective Studies | 2021 |
TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.
Topics: Animals; Galactose; Glomerulonephritis, IGA; Glycosylation; Immunoglobulin A; Interleukin-6; Ligands; Mice; Toll-Like Receptor 9; Tumor Necrosis Factor Ligand Superfamily Member 13 | 2020 |
Immunological Pattern in IgA Nephropathy.
Topics: Fluorescence; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunophenotyping; Leukocytes | 2020 |
Crescentic IgA nephropathy after administration of human monoclonal interleukin-12/23p40 antibody in a patient with Crohn's disease: a case report.
Topics: Adjuvants, Immunologic; Administration, Intravenous; Antibodies, Monoclonal; Complement C3; Crohn Disease; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Injections, Subcutaneous; Interleukin-12; Kidney; Male; Steroids; Treatment Outcome; Withholding Treatment; Young Adult | 2020 |
A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Cytokines; Female; Galactose; Glomerulonephritis, IGA; Humans; IgA Vasculitis; Immunoglobulin A; Inflammation; Kidney Glomerulus; Male | 2020 |
Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
Topics: Adolescent; Adult; Aged; Female; Fluorescent Antibody Technique; Galactose; Glomerulonephritis, IGA; Hepatitis B virus; Humans; Immunoglobulin A; Immunologic Tests; Inflammation; Kidney Glomerulus; Lupus Nephritis; Male; Middle Aged; Retrospective Studies; Staining and Labeling; Vasculitis; Young Adult | 2020 |
Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.
Topics: Adolescent; Age Factors; Biomarkers; Child; Child, Preschool; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Galactosemias; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Male; Predictive Value of Tests; Prognosis; Reference Standards | 2020 |
Rapid progression to end-stage renal disease in a child with IgA-dominant infection-related glomerulonephritis associated with parvovirus B19.
Topics: Antibodies, Monoclonal; Biopsy; Child, Preschool; Disease Progression; Fluorescent Antibody Technique; Galactose; Glomerulonephritis, IGA; Hematuria; Humans; Immunoglobulin A; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Male; Parvovirus B19, Human; Proteinuria | 2020 |
Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.
Topics: Adult; Antibodies, Monoclonal; Antiviral Agents; Arthritis, Rheumatoid; Crohn Disease; Diagnosis, Differential; Female; Galactose; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Hydrocarbons, Fluorinated; Immunoglobulin A; Immunohistochemistry; Kidney; Lupus Erythematosus, Systemic; Male; Middle Aged; Pulse Therapy, Drug; Remission Induction; Steroids; Tonsillectomy; Urea | 2021 |
ST6Gal1 is up-regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome.
Topics: Adult; Antigens, CD; Case-Control Studies; Down-Regulation; Female; Galactose; Galactosyltransferases; Gene Expression Profiling; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Leukocytes, Mononuclear; Male; RNA, Messenger; Sialyltransferases; Transcriptome; Up-Regulation | 2020 |
TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy.
Topics: Adolescent; Adult; Antigens, CD19; B-Lymphocytes; Biomarkers; Female; Galactose; Gene Expression Regulation; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunity, Innate; Immunoglobulin A; Inflammation; Kidney; Male; Middle Aged; N-Acetylgalactosaminyltransferases; Polypeptide N-acetylgalactosaminyltransferase; Renal Insufficiency, Chronic; RNA, Messenger; Toll-Like Receptor 7; Young Adult | 2020 |
Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases.
Topics: Child; Female; Fluorescent Antibody Technique; Galactose; Glomerulonephritis; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Male | 2020 |
Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation.
Topics: Adult; Female; Follow-Up Studies; Galactose; Germinal Center; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney; Kidney Transplantation; Male; Palatine Tonsil; Recurrence; Tonsillectomy; Transplantation, Homologous | 2020 |
Galactose-deficient IgA1 and nephritis-associated plasmin receptors as markers for IgA-dominant infection-related glomerulonephritis: A case report.
Topics: Aged, 80 and over; Biomarkers; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Male; Receptors, Peptide | 2021 |
Interaction between
Topics: Adult; Case-Control Studies; Cohort Studies; Epistasis, Genetic; Female; Galactose; Galactosyltransferases; Gene Frequency; Genome-Wide Association Study; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Male; Multifactorial Inheritance; N-Acetylgalactosaminyltransferases; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Risk Factors; RNA, Messenger | 2021 |
Topics: Adult; Case-Control Studies; Chromatography, Liquid; Cross-Sectional Studies; Female; Galactose; Glomerular Filtration Rate; Glomerulonephritis, IGA; Glycopeptides; Glycosylation; Humans; Immunoglobulin A; Male; Mass Spectrometry; Middle Aged; N-Acetylneuraminic Acid; Polysaccharides | 2021 |
Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA
Topics: Adult; Case-Control Studies; Complement C5a; Complement Pathway, Alternative; Complement System Proteins; Female; Follow-Up Studies; Galactose; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental; Humans; Immunoglobulin A; Male; Middle Aged | 2021 |
Glomerular galactose-deficient IgA1 detected in donor-derived and recurrent IgA nephropathy.
Topics: Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Glomerulus; Tissue Donors | 2021 |
A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy.
Topics: Adult; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Transplantation; Lectins; Male; Postoperative Complications; Recurrence; ROC Curve | 2017 |
IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
Topics: Antibodies, Monoclonal; Biopsy; Fluorescent Antibody Technique; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Glomerulus; Microscopy, Fluorescence; Vasculitis | 2018 |
IgA nephropathy: toward more specific diagnosis (and rescue of snails).
Topics: Animals; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Immunoglobulin A; Snails | 2018 |
Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients.
Topics: Acridines; Animals; Biotinylation; Cells, Cultured; Colorimetry; Enzyme-Linked Immunosorbent Assay; Galactose; Glomerulonephritis, IGA; Glycosylation; Helix, Snails; Humans; Immunoglobulin A; Lectins; Luminescent Measurements; Succinimides | 2018 |
Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
Topics: Adolescent; Adult; Aged; Biomarkers; Biopsy; Female; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Glycosylation; Humans; IgA Vasculitis; Immunoglobulin A; Kidney; Lupus Nephritis; Male; Middle Aged; Proteinuria; Vasculitis; Young Adult | 2018 |
Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1.
Topics: Antibodies, Monoclonal; Antibody Specificity; Epitopes; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A | 2018 |
[Value of galactose-deficient IgA1 in the early diagnosis of Henoch-Schönlein purpura nephritis in children].
Topics: Child; Early Diagnosis; Galactose; Glomerulonephritis, IGA; Humans; IgA Vasculitis; Immunoglobulin A | 2019 |
Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
Topics: Adult; Biomarkers; Case-Control Studies; Creatinine; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Male; Sensitivity and Specificity; Young Adult | 2019 |
Primary IgA Vasculitis with Nephritis in a Patient with Rheumatoid Arthritis Diagnosed by Anti-galactose-deficient IgA1 Immunostaining.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Etanercept; Female; Galactose; Glomerulonephritis, IGA; Humans; IgA Vasculitis; Immunoglobulin A; Middle Aged | 2019 |
ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy.
Topics: Adult; Cell Line, Tumor; Down-Regulation; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Male; Middle Aged; Protein Processing, Post-Translational; Transcriptional Elongation Factors | 2019 |
Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Diagnosis, Differential; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Liver Cirrhosis; Lupus Nephritis; Male; Middle Aged; Psoriasis; Retrospective Studies; Staining and Labeling; Young Adult | 2020 |
Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.
Topics: Adult; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; IgA Vasculitis; Immunoglobulin A; Kidney Diseases; Male; Prognosis; Prospective Studies | 2020 |
Functional implications of regulatory B cells in human IgA nephropathy.
Topics: Adolescent; ADP-ribosyl Cyclase 1; Adult; Aged; Antigens, CD19; B-Lymphocyte Subsets; B-Lymphocytes, Regulatory; B7-2 Antigen; Female; Flow Cytometry; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Interleukin-10; Leukocytes, Mononuclear; Male; Middle Aged; Proteinuria; Tumor Necrosis Factor Receptor Superfamily, Member 7; Young Adult | 2014 |
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
Topics: Adult; Cell Line; Cytokines; Female; Galactose; Galactosyltransferases; Gene Knockdown Techniques; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Interleukin-4; Interleukin-6; Male; N-Acetylneuraminic Acid; Polysaccharides; RNA, Small Interfering; Sialyltransferases | 2014 |
Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Longitudinal Studies; Male; Middle Aged; Tonsillectomy | 2014 |
Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy.
Topics: Cohort Studies; Female; Galactose; Glomerulonephritis, IGA; Glucocorticoids; Glycosylation; Hematuria; Humans; Immunoglobulin A; Male; Methylprednisolone; Protein Processing, Post-Translational; Tonsillectomy; Treatment Outcome | 2014 |
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy?
Topics: Adaptive Immunity; Adolescent; Adult; Advanced Oxidation Protein Products; Case-Control Studies; Cross-Sectional Studies; Cysteine Endopeptidases; Female; Galactose; Gene Expression; Glomerulonephritis, IGA; Healthy Volunteers; Humans; Immunity, Innate; Immunoglobulin A; Male; Middle Aged; Proteasome Endopeptidase Complex; RNA, Messenger; Toll-Like Receptor 2; Toll-Like Receptor 3; Toll-Like Receptor 4; Toll-Like Receptor 9; Toll-Like Receptors; Tonsillectomy; Young Adult | 2015 |
A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Diagnosis, Differential; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Male; Middle Aged | 2014 |
Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals.
Topics: Adult; Antigens, Tumor-Associated, Carbohydrate; B-Lymphocytes; Female; Galactose; Galactosyltransferases; Glomerular Mesangium; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Inflammation; Lectins; Male; Peanut Agglutinin; Polysaccharides; Sialyltransferases; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
Topics: Autoantigens; Cells, Cultured; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Mass Spectrometry; N-Acetylneuraminic Acid; Recombinant Proteins; Sialyltransferases | 2015 |
A new monoclonal antibody for detecting degalactosylated IgA1 as serum biomarker of IgA nephropathy.
Topics: Animals; Biomarkers; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Glomerulus; Lectins | 2015 |
Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
Topics: Agglutinins; Animals; Antibodies, Monoclonal; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Glomerulus; Lectins; Rats; Rats, Sprague-Dawley | 2015 |
Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
Topics: Adult; Aged; Antigen-Antibody Complex; Cell Proliferation; Cells, Cultured; Chemokine CCL5; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunologic Factors; Interleukin-6; Male; Mesangial Cells; Phenotype; Transforming Growth Factor beta1; Young Adult | 2016 |
Glyco-engineering for the production of recombinant IgA1 with distinct mucin-type O-glycans in plants.
Topics: Antigen-Antibody Complex; Galactose; Gene Expression Regulation; Genetic Engineering; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Mucins; Nicotiana; Polysaccharides; Recombinant Proteins | 2016 |
Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
Topics: Biomarkers; Blotting, Western; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Lectins; Peptide Fragments; Prognosis | 2016 |
Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.
Topics: Antibodies, Monoclonal; Basiliximab; Drug Therapy, Combination; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Immunosuppressive Agents; Kidney; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recombinant Fusion Proteins; Sirolimus; Tacrolimus | 2016 |
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway.
Topics: Alleles; Asian People; Cell Line; Cohort Studies; Galactose; Galactosyltransferases; Gene Expression Regulation; Gene Frequency; Gene Regulatory Networks; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Models, Genetic; Molecular Chaperones; Nerve Tissue Proteins; Phenotype; Polymorphism, Single Nucleotide; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Ubiquitin-Protein Ligases; White People | 2017 |
Galactosylation of IgA1 Is Associated with Common Variation in
Topics: Female; Galactose; Galactosyltransferases; Genetic Variation; Genome-Wide Association Study; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Male | 2017 |
[Advances in primary glomerular disease in 2007].
Topics: Galactose; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glycosylation; Humans; Immunoglobulin A; Immunosuppressive Agents; Prognosis; Prospective Studies; Protein Processing, Post-Translational; Proteinuria | 2008 |
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
Topics: Acetylglucosamine; Adult; Amino Acid Sequence; Antibody Specificity; Cell Line; Female; Galactose; Glomerulonephritis, IGA; Glycosylation; Health; Humans; Immunoglobulin A; Immunoglobulin G; Molecular Sequence Data | 2009 |
Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy.
Topics: Adult; Female; Galactose; Genes, Immunoglobulin; Genetic Predisposition to Disease; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Male | 2009 |
Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1.
Topics: Adult; Galactose; Glomerulonephritis; Glomerulonephritis, IGA; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin A; Kidney; Male; Middle Aged | 2010 |
Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
Topics: Acetylgalactosamine; Agglutinins; Animals; Antibodies, Anti-Idiotypic; Antigen-Antibody Complex; Binding Sites; Epitopes; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Kidney; Lectins; Myeloma Proteins; Polysaccharides; Snails | 2010 |
Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Biopsy; Black or African American; Case-Control Studies; Child; Female; Galactose; Genetic Predisposition to Disease; Glomerulonephritis, IGA; Glycosylation; Heredity; Humans; Immunoglobulin A; Male; Middle Aged; Pedigree; Phenotype; Protein Processing, Post-Translational; Risk Assessment; Risk Factors; Up-Regulation; Young Adult | 2010 |
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
Topics: Adolescent; Biomarkers; Case-Control Studies; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Glomerulonephritis, IGA; Glycation End Products, Advanced; Glycosylation; Humans; Immunoglobulin A; Italy; Least-Squares Analysis; Linear Models; Male; Oxidative Stress; Predictive Value of Tests; Serum Albumin; Time Factors; United States; Up-Regulation; Young Adult | 2011 |
IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.
Topics: Adolescent; Adult; Antigen-Antibody Complex; Blotting, Western; Cell Proliferation; Cells, Cultured; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Glomerular Filtration Rate; Glomerular Mesangium; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoenzyme Techniques; Immunoglobulin A; Interleukin-6; Interleukin-8; Male; Mesangial Cells; Real-Time Polymerase Chain Reaction; RNA, Messenger; Young Adult | 2011 |
Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Topics: Adult; Aged; Antigen-Antibody Complex; Antigens, CD; Biopsy; Cell Proliferation; Cells, Cultured; Female; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Immunoglobulin G; Kidney; Liver Cirrhosis, Alcoholic; Male; Mesangial Cells; Middle Aged; Paris; Receptors, Fc | 2011 |
The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression.
Topics: Adolescent; Adult; Aged; Biomarkers; Case-Control Studies; Chi-Square Distribution; China; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Renal Insufficiency; Risk Assessment; Risk Factors; Time Factors; Up-Regulation; Young Adult | 2012 |
Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.
Topics: Adolescent; Adult; Aged; Autoantibodies; Autoantigens; Biopsy; Case-Control Studies; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Kaplan-Meier Estimate; Kidney; Male; Middle Aged; Prospective Studies; Survival Rate; Young Adult | 2012 |
Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy.
Topics: Adolescent; Biopsy; Child; Female; Fluorescent Antibody Technique; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Kidney; Male | 2012 |
Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
Topics: Acetylgalactosamine; Adult; Biopsy; Female; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Kidney; Male; N-Acetylneuraminic Acid; Phenotype; Severity of Illness Index | 2005 |
The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Topics: Acetylgalactosamine; Adult; Chemical Precipitation; Female; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Immunoglobulin G; Kidney Glomerulus; Lectins; Macromolecular Substances; Male; N-Acetylneuraminic Acid; Phenotype; Polysaccharides; Sclerosis; Severity of Illness Index | 2005 |
O-glycosylation of serum IgD in IgA nephropathy.
Topics: Adult; Aged; B-Lymphocytes; Binding Sites; Carbohydrate Sequence; Case-Control Studies; Cell Differentiation; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Immunoglobulin D; Lectins; Male; Middle Aged; Molecular Sequence Data | 2006 |
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
Topics: Acetylgalactosamine; Adolescent; Adult; Animals; Blotting, Western; Carbohydrate Sequence; Diagnostic Tests, Routine; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Glycosylation; Helix, Snails; Humans; Immunoglobulin A; Lectins; Male; Middle Aged; O Antigens; Sensitivity and Specificity | 2007 |
Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura.
Topics: Adolescent; Child; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; IgA Vasculitis; Immunoglobulin A; Lectins; Male | 2007 |
Glycosylation profile of differently charged IgA1 and their binding characteristics to cultured mesangial cells in IgA nephropathy.
Topics: Acetylgalactosamine; Adult; Anions; Binding, Competitive; Cations; Cell Line, Tumor; Cells, Cultured; Female; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Male; Mesangial Cells; Middle Aged; N-Acetylneuraminic Acid; Neuraminidase; Protein Binding; Protein Processing, Post-Translational | 2007 |
Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy.
Topics: Amino Acid Sequence; Animals; Carbohydrate Sequence; Carbohydrates; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Immunoglobulin Heavy Chains; Lectins; Liver; Mice; Molecular Sequence Data; Plant Lectins; Primates; Protein Processing, Post-Translational | 1993 |
IgA nephropathy. A disease of incomplete IgA 1 glycosylation?
Topics: Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A | 1995 |
Aberrant glycosylation of IgA from patients with IgA nephropathy.
Topics: Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Immunoglobulin Fc Fragments; Kidney Glomerulus | 1996 |
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG.
Topics: Adult; Carbohydrate Sequence; Chromatography, High Pressure Liquid; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lectins; Male; Middle Aged; Molecular Sequence Data; Proteoglycans | 1997 |
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
Topics: Acetylgalactosamine; Adult; Antibody Specificity; Antigen-Antibody Complex; Autoantibodies; Autoantigens; Carbohydrate Conformation; Carbohydrate Sequence; Epitopes; Female; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Immunoglobulin G; Male; Middle Aged; Molecular Sequence Data; Myeloma Proteins; Neuraminidase; Polysaccharides; Protein Processing, Post-Translational | 1999 |
Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.
Topics: Adult; Carbohydrate Sequence; Case-Control Studies; Galactose; Gas Chromatography-Mass Spectrometry; Glomerulonephritis; Glomerulonephritis, IGA; Glycopeptides; Humans; Immunoglobulin A; Mass Spectrometry; Middle Aged; Molecular Sequence Data; N-Acetylneuraminic Acid; Peptides | 2000 |
Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA.
Topics: Antibodies, Monoclonal; Apoptosis; Cells, Cultured; Extracellular Matrix; Flow Cytometry; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoenzyme Techniques; Immunoglobulin A; In Vitro Techniques; Integrin alpha3beta1; Integrins; Kidney Glomerulus; Macromolecular Substances; N-Acetylneuraminic Acid; Receptors, Vitronectin | 2000 |
The interaction of selective plant lectins with neuraminidase-treated and untreated IgA1 from the sera of IgA nephropathy patients.
Topics: Adult; Binding Sites; Case-Control Studies; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; In Vitro Techniques; Lectins; Middle Aged; N-Acetylneuraminic Acid; Neuraminidase; Plant Lectins; Ribosome Inactivating Proteins; Soybean Proteins | 2001 |
Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells.
Topics: Apoptosis; Cell Division; Cells, Cultured; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Glycoproteins; Glycosylation; Humans; Immunoglobulin A; Reference Values; Sialic Acids | 2001 |
IgA-associated renal diseases: immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions.
Topics: Acetylgalactosamine; Acetylglucosamine; Antigen-Antibody Complex; Fibronectins; Fluorescent Antibody Technique; Fucose; Galactose; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunochemistry; Immunoglobulin A; Immunoglobulin G; Kidney Glomerulus; Mannose; Myeloma Proteins | 1987 |
Anti-alpha-galactosyl antibodies and immune complexes in children with Henoch-Schönlein purpura or IgA nephropathy.
Topics: Adolescent; Antigen-Antibody Complex; Child; Child, Preschool; Electrophoresis, Polyacrylamide Gel; Female; Galactose; Glomerulonephritis, IGA; Hematuria; Humans; IgA Vasculitis; Immunoglobulin A; Male | 1987 |